Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.

MLA

Barham, Whitney, et al. “Aberrant Activation of NF-ΚB Signaling in Mammary Epithelium Leads to Abnormal Growth and Ductal Carcinoma in Situ.” BMC Cancer, vol. 15, Sept. 2015, p. 647. EBSCOhost, https://doi.org/10.1186/s12885-015-1652-8.

APA

Barham, W., Chen, L., Tikhomirov, O., Onishko, H., Gleaves, L., Stricker, T. P., Blackwell, T. S., & Yull, F. E. (2015). Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. BMC Cancer, 15, 647. https://doi.org/10.1186/s12885-015-1652-8

Chicago

Barham, Whitney, Lianyi Chen, Oleg Tikhomirov, Halina Onishko, Linda Gleaves, Thomas P Stricker, Timothy S Blackwell, and Fiona E Yull. 2015. “Aberrant Activation of NF-ΚB Signaling in Mammary Epithelium Leads to Abnormal Growth and Ductal Carcinoma in Situ.” BMC Cancer 15 (September): 647. doi:10.1186/s12885-015-1652-8.